arrow
J

James Sun

new york university
H指数:31
被引数:7,862

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Mapping intraoperative interictal epileptiform discharges using high-resolution, thin-film cortical arrays

使用高分辨率薄膜皮层阵列对术中间期癫痫样放电进行定位

2026-02-260
PRE
Blood-Based MCED Testing During Routine Colonoscopy to Enhance Early Detection of High Mortality Gastrointestinal Cancers

基于血液的MCED检测在常规结肠镜检查中的应用,以增强对高死亡率胃肠道癌症的早期发现

2025-10-010
PRE
Patterns of recurrence and prognosis in pathologic stage I and II Merkel cell carcinoma: A multicenter, retrospective cohort analysis
2023-01-010
PRE
ASO Visual Abstract: An Internally Validated Prognostic Risk Score Model for Disease-Specific Survival in Clinical Stage I and II Merkel Cell Carcinoma
2022-07-270
PRE
An Internally Validated Prognostic Risk-Score Model for Disease-Specific Survival in Clinical Stage I and II Merkel Cell Carcinoma
2022-07-221
PRE
The efficacy of immune checkpoint blockade for melanoma in-transit with or without nodal metastases - A multicenter cohort study

免疫检查点阻断对有或没有淋巴结转移的黑色素瘤的疗效-一项多中心队列研究

2022-07-0117
OA
ASO Visual Abstract: Talimogene Laherparepvec (T-VEC) for Treatment of Advanced Locoregional Melanoma after Failure of Immunotherapy: An International Multi-institutional Experience
2021-11-241
PRE
Talimogene Laherparepvec (T-VEC) for the Treatment of Advanced Locoregional Melanoma After Failure of Immunotherapy: An International Multi-Institutional Experience
2021-10-1420
PRE
Predictors of False Negative Sentinel Lymph Node Biopsy in Clinically Localized Merkel Cell Carcinoma
2021-04-227
PRE
Active surveillance of patients who have sentinel node positive melanoma: An international, multi-institution evaluation of adoption and early outcomes after the Multicenter Selective Lymphadenectomy trial II (MSLT-2)
CANCER
IF5.1
2021-04-0750
OAAI
Surveillance of Sentinel Node-Positive Melanoma Patients with Reasons for Exclusion from MSLT-II: Multi-Institutional Propensity Score Matched Analysis
2021-04-0115
OAAI